Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.

NCT02241499 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of the Esophagus or Esophagogastric Junction

Interventions

RADIATION: Radiation therapy
DRUG: Oxaliplatin and fluorouracil.

Sponsor

Lund University Hospital